Document is current
Any future updates will be listed below
-
Authors
Kenny, Connor J.
McGurk, Michael P.
Schüler, Sandra https://orcid.org/0009-0002-6418-6820
Cordero, Aidan
Laubinger, Sascha https://orcid.org/0000-0002-6682-0728
Burge, Christopher B. https://orcid.org/0000-0001-9047-5648
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM085319)
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 21 January 2025
First Online: 20 February 2025
Competing interests
: C.B.B. is a member of the Scientific Advisory Board of Remix Therapeutics and has equity interests in Remix Therapeutics and Arrakis Therapeutics: both companies are developing small molecule therapeutics targeting RNA. The authors claim no other competing interests with respect to this work.
